Futura Medical PLC
LSE:FUM
Balance Sheet
Balance Sheet Decomposition
Futura Medical PLC
Futura Medical PLC
Balance Sheet
Futura Medical PLC
| Jan-2002 | Jan-2003 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
2
|
2
|
2
|
4
|
2
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
2
|
1
|
10
|
4
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
2
|
1
|
10
|
4
|
0
|
0
|
|
| Cash Equivalents |
2
|
2
|
2
|
4
|
2
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
2
|
1
|
2
|
3
|
1
|
9
|
4
|
12
|
8
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
2
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Assets |
2
|
2
|
3
|
4
|
2
|
4
|
3
|
1
|
2
|
1
|
3
|
3
|
1
|
10
|
5
|
13
|
10
|
11
|
5
|
2
|
11
|
5
|
9
|
10
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
2
-22%
|
3
+46%
|
4
+53%
|
2
-44%
|
4
+89%
|
3
-26%
|
1
-66%
|
2
+100%
|
1
-50%
|
3
+181%
|
3
+9%
|
1
-54%
|
10
+603%
|
6
-47%
|
13
+144%
|
10
-29%
|
11
+13%
|
5
-55%
|
2
-67%
|
12
+629%
|
6
-45%
|
12
+83%
|
14
+15%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
0
|
1
|
0
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
2
|
5
|
1
|
2
|
2
|
6
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Liabilities |
0
N/A
|
0
-4%
|
0
-28%
|
0
+28%
|
0
+4%
|
0
-4%
|
0
+39%
|
0
-53%
|
0
+47%
|
0
-32%
|
0
+27%
|
0
+74%
|
0
+45%
|
1
+27%
|
1
+20%
|
1
+17%
|
0
-42%
|
2
+306%
|
5
+139%
|
1
-84%
|
2
+171%
|
2
-16%
|
6
+262%
|
5
-27%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
1
|
2
|
4
|
5
|
7
|
8
|
11
|
12
|
14
|
15
|
17
|
19
|
21
|
24
|
28
|
32
|
36
|
42
|
50
|
52
|
57
|
62
|
66
|
63
|
|
| Additional Paid In Capital |
3
|
4
|
6
|
8
|
9
|
12
|
13
|
13
|
16
|
16
|
19
|
21
|
22
|
33
|
33
|
44
|
45
|
50
|
50
|
53
|
66
|
67
|
71
|
71
|
|
| Total Equity |
2
N/A
|
2
-24%
|
2
+59%
|
4
+56%
|
2
-47%
|
4
+99%
|
3
-30%
|
1
-68%
|
2
+108%
|
1
-51%
|
3
+207%
|
3
+4%
|
1
-66%
|
10
+882%
|
5
-51%
|
13
+163%
|
9
-28%
|
9
-3%
|
0
-99%
|
1
+1 489%
|
10
+1 039%
|
5
-51%
|
5
+16%
|
9
+64%
|
|
| Total Liabilities & Equity |
2
N/A
|
2
-22%
|
3
+46%
|
4
+53%
|
2
-44%
|
4
+88%
|
3
-26%
|
1
-66%
|
2
+100%
|
1
-50%
|
3
+181%
|
3
+9%
|
1
-54%
|
10
+603%
|
6
-47%
|
13
+144%
|
10
-29%
|
11
+13%
|
5
-55%
|
2
-67%
|
12
+629%
|
6
-45%
|
12
+83%
|
14
+15%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
41
|
42
|
46
|
49
|
49
|
56
|
58
|
58
|
68
|
68
|
74
|
78
|
78
|
100
|
100
|
121
|
121
|
205
|
205
|
246
|
287
|
288
|
301
|
304
|
|